Authors


Shripad Gadhinglajkar

Latest:

Controlling the Release of Highly Dosed and Highly Soluble Drugs

The authors formulated bupropion hydrochloride tablets with various grades of methacrylic copolymers and analyzed the properties of the resulting dosage forms. This article is part of PharmTech's supplement "Solid Dosage and Excipients 2010."


Richard Bhella

Latest:

Developing Sterile Packaging For Aseptic Environments

The growing uptake of single-use sterile packaging in pharmaceutical production processes mirrors the broader trend towards single-use across every sector of the pharmaceutical industry.


Brad Swanson

Latest:

Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity Testing

The authors describe an industrialized process for the manufacture of iPSC-derived human cardiomyocytes. This article is part of a special issue on Bioprocessing and Sterile Manufacturing.


Kevin Smith

Latest:

Analytical Data Management and Archiving: 21 CFR Part 11 Compliance and Beyond

Pharma laboratories are having to manage and archive more analytical data than ever before. With effective implementation of IT systems, companies can successfully prepare their electronic files for future retieval and use.


Lucy Foley

Latest:

Commercialising cellular therapies faster

There is much scientific evidence of the early successes of whole cell therapies as disease cures in chronic conditions and disease-modifiers in acute conditions, but limited cases of successfully transferring these discoveries to commercial products or therapies.


Christophe Sanfilippo

Latest:

Needle-free diluent technology

The Needle-Free diluent kit is a concept created by bioluz and Technoflex in response to the FDA and the UK?s National Health Service (NHS) publishing recommendations to prevent healthcare staff from needle-stick injuries during the reconstitution of intravenous (IV) drugs.


Mark Davison

Latest:

Applying Universal Anticounterfeiting Technologies

It is very difficult to measure the problem of counterfeiting accurately from year to year; by definition criminals don?t file tax returns or publish quarterly earnings.


Thomas Paust

Latest:

The Evolution of Single-Use Technologies in Aseptic Processing

The authors describe the origins of single-use components and explain their application to aseptic processes. They also show how disposable devices have changed over time and offer a glimpse of the future.


William Brock

Latest:

Regulatory Update: The IPEC Novel Excipient Safety Evaluation Procedure

The authors, representing the International Pharmaceutical Excipients Council, propose a new evaluation procedure, including tiered toxicology testing for excipients.


Wayne Jalenak

Latest:

Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer

Using handheld Raman spectroscopy, methods were developed and evaluated for 198 substances widely used as raw materials.


Dianne Sharp

Latest:

How A CMO Can Compete In An Increasingly Competitive Market

In an increasingly competitive landscape, outsourcing providers are under mounting pressure to get their name out there and secure new and repeat business.


Warren Potts

Latest:

Impurity Profiling Using Convergence Chromatography and Mass Spectrometry

The authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling.


Glenn E. Wright

Latest:

The PQRI Aseptic Processing Working Group: What was it? What Did It Cover? What Conclusions Did It Reach? Why Was It Important?

Members of FDA, industry, and academia formed a working group within PQRI to openly discuss topics from a scientific perspective and provide formalized clarifications and recommendations to FDA to be considered and incorporated into FDA's draft guidance on aseptic processing.


James Bergum

Latest:

A Proposed Content-Uniformity Test for Large Sample Sizes

The authors describe a modified version of the Large-N test used to determine content uniformity.


Janie Dubois

Latest:

When and why should the pharmaceutical industry use NIR chemical imaging?

The author assesses the power and limitations of NIR chemical imaging and its future.


Chris Hamilton

Latest:

Making a CRO project run smoothly

When embarking on a new outsourcing project, there are a few initial steps that must be taken to ensure a project runs smoothly from the start.


John Roberts

Latest:

Quantitative open-access HPLC analysis: a new calibration approach

A novel tool enables users to generate reliable data for yields in solution and for assays of isolated solids using high?performance liquid chromatography without having to prepare standards.


Breda O’Driscoll

Latest:

High-Resolution Ultrasonic Spectroscopy: Analysis of Microemulsions

This article introduces the application of high-resolution ultrasonic spectroscopy (HR-US) for the analysis of emulsions and suspensions. The authors outline the principles of the technique and illustrate its application for analysis of the crystallization of lysozyme and the formation of a microemulsion.


Paul Smith

Latest:

Data Integrity in the Analytical Laboratory

Data integrity in the analytical laboratory is an area of increasing focus for regulators such as FDA.


Laila Kott

Latest:

A New Approach to Forced Degradation Studies Using Anhydrous Conditions

In this article, the authors demonstrate that a normal-phase chromatographic method was stability-indicating for a water-sensitive prodrug. The stress conditions using aqueous and non-aqueous conditions were also compared to understand the information obtained with each approach.


Jerry Martin

Latest:

Reducing the risk of microbial contamination

Maintaining asepsis and sterility is the primary challenge to implementing aseptic techniques and sterile processes in biopharmaceutical manufacture. Efforts to reduce the risk of microbial contamination of aseptically filled biotech products beyond their already low level represent engineering challenges, that don?t really compliment the progress in biotech R&D.


Gerallt Williams

Latest:

Understanding The Requirements For Effective Nasal Drug Delivery

One particularly crucial parameter for nasal sprays is the size of the droplets produced during actuation, which can potentially impact bioavailability.


Kim Erland Vukovinsky

Latest:

The Role of Normal Data Distribution in Pharmaceutical Development and Manufacturing

Review challenges in the use of normality testing situations and recommendations on how to assess data distributions in the pharmaceutical development manufacturing environment


Robert Osterberg

Latest:

Regulatory Update: The IPEC Novel Excipient Safety Evaluation Procedure

The authors, representing the International Pharmaceutical Excipients Council, propose a new evaluation procedure, including tiered toxicology testing for excipients.


Hank Rahe

Latest:

Designing Transfer Carts for Class 100 Conditions

FDA has found several pharmaceutical companies not maintaining Class 100 conditions within transfer carts. The author discusses an approach for designing a transfer cart that will satisfy such conditions.


Detelv Szarafinksi

Latest:

A Detail View of Single-Use Equipment Opportunities

The authors propose increased use of single-use technologies in biopharmaceutical manufacturing to achieve operational excellence without compromising product quality.


Thomas Kraft

Latest:

Filling of Asthma Inhalers with Liquid Nitrogen: Cryogenic Product Cooling of Aerosol Propellants

This case study describes how a major pharmaceutical manufacturer was equipped with four filling lines, for metered dose inhalers, supplied with a nitrogen cooling system to prevent spontaneous vaporization of the propellant gas. By doing so, a cost-effective and environmentally friendly solution was provided to a hazardous situation, which also complied with regulatory directives.


Andrew Lyddiatt

Latest:

Commercialising cellular therapies faster

There is much scientific evidence of the early successes of whole cell therapies as disease cures in chronic conditions and disease-modifiers in acute conditions, but limited cases of successfully transferring these discoveries to commercial products or therapies.


Ismat Ullah

Latest:

Moisture-Activated Dry Granulation

Moisture Activated Dry Granulation (MADG) was developed in response to the difficulties experienced with wet granulation, in terms of endpoint, drying and milling. Wet granulation process endpoint is very sensitive to granulation time and shear. The wet granules need to be dried to a narrow range of moisture contents, which is difficult. The dried granules need to be milled, but the milled granules often have either too many fines or too many coarse particles (or both) - an undesirable bimodal distribution.


Matthias Pohl

Latest:

Implications and Opportunities of Applying QbD Principles to Analytical Measurement

The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.